19 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model.

University of California Irvine
Affinity-Guided Design of Caveolin-1 Ligands for Deoligomerization.

University of California Irvine
Design, synthesis, and activity of a series of arylpyrid-3-ylmethanones as type I positive allosteric modulators of a7 nicotinic acetylcholine receptors.

University of California Irvine
Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity.

University of California Irvine
The selective inhibition of phosphatases by natural toxins: the anhydride domain of tautomycin is not a primary factor in controlling PP1/PP2A selectivity.

University of California Irvine
Enaminone amides as novel orally active GABAA receptor modulators.

University of California Irvine
Microcystin analogues comprised only of Adda and a single additional amino acid retain moderate activity as PP1/PP2A inhibitors.

University of California Irvine
Linearized and truncated microcystin analogues as inhibitors of protein phosphatases 1 and 2A.

University of California Irvine
Compounds and compositions as inhibitors of MEK

Novartis
ERK2 in CSAR_FULL_RELEASE_3JULY2012

Csar
Endocrinological properties of two novel nonsteroidal progesterone receptor modulators, CP8816 and CP8863.

Meiji Seika Kaisha
Dual aromatase-steroid sulfatase inhibitors.

University of Bath
Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK.

Glaxosmithkline
Thermodynamic and structure guided design of statin based inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.

Boehringer Ingelheim Pharmaceuticals